Human hepatoma cell mutant defective in cell surface protein trafficking
Related Experiment Video
Updated: Aug 17, 2026

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
R J Stockert1, B Potvin, L Tao
1Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
To isolate a mutant liver cell defective in the endocytic pathway, a selection strategy using toxic ligands for two distinct membrane receptors was devised. Ovalbumin-gelonin and asialoorosomucoid (ASOR)-gelonin were incubated with mutagenized HuH-7 cells, and a rare survivor termed trafficking mutant 1 (Trf1) was isolated. Trf1 cells were stably 3-fold more resistant than the parental HuH-7 to both toxic conjugates. The anterograde steps of intracellular endocytic processing of ASOR, including internalization, endosomal acidification, and ligand degradation, were unaltered in Trf1 cells. In contrast, retrograde diacytosis of asialoglycoprotein receptor (ASGR).ASOR complex back to the cell surface was enhanced by about 250%. Selective labeling revealed an approximately 46% reduction in cell surface-associated ASGR in Trf1 cells, although their total cellular ASGR content was essentially equivalent to that in HuH-7. Similar results were obtained with the transferrin receptor. Binding of 125I-ASOR and 125I-transferrin was reduced in Trf1 cells to 49 +/- 2.5% and 30 +/- 2%, respectively, of HuH-7 cells. The methionine transporter was also reduced in Trf1 cells, as revealed by a 2-fold reduction in Vmax with no change in apparent Km. Pretreatment with monensin, sodium azide, or colchicine reduced surface binding of 125I-ASOR in HuH-7 cells by 50% but had no effect on binding to Trf1 cells. This result is predicted for a cell that expresses only State 1 ASGRs, which are resistant to modulation by metabolic and cytoskeletal inhibitors in contrast to State 2, which are responsive to these agents (Weigel, P. H., and Oka, J. A. (1984) J. Biol. Chem. 259, 1150-1154). The Trf1 mutant, having lost the ability to express State 2 receptors, provides genetic evidence for the existence of these two receptor subpopulations and an approach to identifying the biochemical mechanism by which they are generated.
Insights
Researchers isolated a novel liver cell mutant (Trf1) defective in endocytic trafficking. This mutant exhibits enhanced retrograde transport and reduced cell surface receptors, providing insights into receptor subpopulations.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Endocytic pathways are crucial for cellular processes, involving receptor-mediated uptake and intracellular trafficking.
- Distinct receptor subpopulations may exist, differing in their surface expression and response to cellular modulation.
- Understanding these subpopulations is key to elucidating the mechanisms of receptor regulation.
Purpose of the Study:
- To isolate and characterize a liver cell mutant with defects in endocytic trafficking.
- To investigate the role of specific cellular pathways in regulating cell surface receptor expression.
- To provide genetic evidence for distinct receptor subpopulations and their generation mechanisms.
Main Methods:
- A selection strategy using toxic ligands conjugated to ovalbumin and asialoorosomucoid (ASOR) was employed.
- Mutagenized HuH-7 liver cells were screened for resistance to these toxic conjugates, leading to the isolation of the Trf1 mutant.
- Flow cytometry, radioligand binding assays, and kinetic analyses were used to assess receptor expression and function.
Main Results:
- The Trf1 mutant showed a 3-fold resistance to toxic receptor ligands compared to parental cells.
- While anterograde endocytic steps were normal, retrograde diacytosis of the asialoglycoprotein receptor (ASGR).ASOR complex was enhanced by 250%.
- Trf1 cells exhibited reduced cell surface ASGR, transferrin receptor, and methionine transporter levels, with altered responses to metabolic and cytoskeletal inhibitors.
Conclusions:
- The Trf1 mutant demonstrates a defect in endocytic trafficking, specifically enhancing retrograde transport.
- The findings provide genetic evidence for the existence of at least two distinct subpopulations of cell surface receptors (State 1 and State 2 ASGRs).
- This mutant offers a valuable tool for identifying the biochemical mechanisms underlying the generation of these receptor subpopulations.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022